Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma
Globe Newswire•10/08/2026•08:47 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.